文献速递关节外科

非头孢唑林抗生素预防与全膝关节置换术后假体周围关节感染风险增加相关

Noncefazolin Antibiotic Prophylaxis Is Associated With Increased Periprosthetic Joint Infection Risk Following Total Knee Arthroplasty.
PubMed 文献 · J Arthroplasty · 2025-06-21

基于2016至2022年全国数据库528,250例初次全膝关节置换术患者,比较头孢唑林单用、非头孢唑林单用及头孢唑林联合其他抗生素三种预防方案的90天假体周围关节感染风险。多因素校正后,头孢唑林单用(OR 0.68,95%CI 0.62-0.75)和联合方案(OR 0.74,95%CI 0.66-0.82)均与假体周围关节感染几率降低相关。

要点

  • 90天假体周围关节感染率:非头孢唑林组1.0% vs 头孢唑林单用组0.7% vs 联合组0.7%(P<0.001)。
  • 校正混杂因素后,头孢唑林单用组假体周围关节感染风险低于非头孢唑林组,OR 0.68(95%CI 0.62-0.75)。
  • 头孢唑林联合其他抗生素组假体周围关节感染风险亦低于非头孢唑林组,OR 0.74(95%CI 0.66-0.82)。

核心结论

  • 全国代表性数据证实,与替代抗生素相比,头孢唑林预防可显著降低全膝关节置换术后90天假体周围关节感染风险。
  • 作者认为,外科医生在偏离以头孢唑林为基础的预防方案前应仔细考虑患者过敏情况。
  • 作者提出,未来研究应明确对报告头孢唑林过敏的患者及感染风险较高患者(尤其是免疫功能受损者)的最佳预防策略。

研究设计与样本

  • 基于全国数据库2016至2022年数据的分析,纳入528,250例初次全膝关节置换术患者。
  • 使用当前操作术语代码27447及国际疾病分类操作编码系统代码(0SRD0xx、0SRC0xx)识别手术,并链接至骨关节炎(国际疾病分类临床修改版M17)。
  • 比较三组预防方案:头孢唑林单用343,279例(65.0%)、非头孢唑林单用53,776例(10.2%)、头孢唑林联合其他抗生素131,195例(24.8%)。
  • 采用多分类逻辑回归评估抗生素使用与假体周围关节感染的关联,校正年龄、性别、支付方、种族、民族及合并症。
  • 假体周围关节感染依据美国医疗保险和医疗补助服务中心并发症测量代码定义,为90天内发生。

主要发现

  • 单因素分析显示90天假体周围关节感染率:非头孢唑林组1.0% vs 头孢唑林单用组0.7% vs 联合组0.7%(P<0.001)。
  • 校正年龄、性别、支付方、种族、民族及合并症后,头孢唑林单用与非头孢唑林相比,假体周围关节感染比值比OR 0.68(95%CI 0.62-0.75,P<0.001)。
  • 校正后头孢唑林联合其他抗生素与非头孢唑林相比,假体周围关节感染比值比OR 0.74(95%CI 0.66-0.82,P<0.001)。

关键数值与推荐

  • 假体周围关节感染定义:依据美国医疗保险和医疗补助服务中心并发症测量代码,90天内发生。
  • 研究纳入标准:当前操作术语代码27447及国际疾病分类操作编码系统代码0SRD0xx或0SRC0xx,链接至骨关节炎(国际疾病分类临床修改版M17)的初次全膝关节置换术。

临床怎么用

  • 作者认为,外科医生在偏离以头孢唑林为基础的预防方案前应仔细考虑患者过敏情况。
  • 作者提出,未来研究应明确对报告头孢唑林过敏的患者及感染风险较高患者(尤其是免疫功能受损者)的最佳预防策略。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Conflicting reports exist on the relationship between antibiotic choice and periprosthetic joint infection (PJI) after total knee arthroplasty (TKA). We used a national database to investigate whether cefazolin usage reduced PJI risk compared with alternatives. METHODS: We queried a national database from 2016 to 2022 to identify primary TKAs using Current Procedural Terminology code 27447 and International Classification of Diseases Procedure Coding System codes (0SRD0xx, 0SRC0xx) linked to osteoarthritis (International Classification of Diseases Clinical Modification M17). This study included 528,250 primary TKA patients. A total of 53,776 (10.2%) received noncefazolin alone, 343,279 (65.0%) received cefazolin only, and 131,195 (24.8%) received cefazolin plus another antibiotic. Demographics, clinical characteristics, and outcomes were extracted. The PJIs were defined according to Centers for Medicare and Medicaid Services complication measure codes within 90 days. We compared three prophylaxis groups: cefazolin only, noncefazolin, or cefazolin plus another antibiotic. Multinomial logistic regression assessed the association between antibiotic use and PJI. RESULTS: Univariate analysis showed 90-day PJI rates of 1.0% in noncefazolin versus 0.7% in both cefazolin-only and combination groups (P < 0.001). After adjusting for age, sex, payer, race, ethnicity, and comorbidities, both cefazolin-only (odds ratio 0.68, 95% confidence interval 0.62 to 0.75, P < 0.001) and cefazolin plus another antibiotic (odds ratio 0.74, 95% confidence interval 0.66 to 0.82, P < 0.001) were associated with reduced odds of PJI. CONCLUSIONS: In conclusion, our nationally representative findings confirm that cefazolin prophylaxis significantly lowers 90-day PJI risk after TKA compared to alternative antibiotics. Surgeons should carefully consider patient allergies before deviating from cefazolin-based prophylaxis. Future research should clarify optimal strategies for patients reporting cefazolin allergies and those at higher infection risk, particularly immunocompromized patients.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Rumalla KC, Sontag-Milobsky IL, Chen AR, et al. Noncefazolin Antibiotic Prophylaxis Is Associated With Increased Periprosthetic Joint Infection Risk Following Total Knee Arthroplasty. J Arthroplasty. 2025. PMID: 40550376. doi:10.1016/j.arth.2025.06.057

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。